All Stories

  1. Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

    Article • OncoTargets and Therapy, July 2013, Taylor & Francis

    Dr Arlhee Diaz-Miqueli, Dr Giselle Saurez